Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-20-003393
Accepted
2020-12-04 00:15:37
Documents
1
Effectiveness Date
2020-12-03
Registration Form
S-1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 596
  Complete submission text file 9999999995-20-003393.txt   1712
Mailing Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142 617-336-7540
Sigilon Therapeutics, Inc. (Filer) CIK: 0001821323 (see all company filings)

EIN.: 474005543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-250070 | Film No.: 201368656
SIC: 2834 Pharmaceutical Preparations